NCT04586608 (MCT/ω-3 FA) is a NA clinical trial of MCT/ω-3 fatty acids in Premature Birth, sponsored by Iaso Maternity Hospital, Athens, Greece.

Who is sponsoring NCT04586608?

NCT04586608 is sponsored by Iaso Maternity Hospital, Athens, Greece.

What drugs are being tested in NCT04586608?

Interventions in NCT04586608: MCT/ω-3 fatty acids, soybean oil-based IVFE.

What condition does NCT04586608 study?

NCT04586608 studies Premature Birth.

Is NCT04586608 still recruiting?

NCT04586608 is currently completed. Last updated 19 October 2020.

Last reviewed 2020-10-19 · How we verify

NCT04586608: MCT/ω-3 FA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation of Administration of MCT/ω-3 Fatty Acids is Towards Anti-inflammatory Related Fatty Acid Profile in Preterm Neonates.

Completed NA Last updated 19 October 2020

What this trial tests

NA trial testing MCT/ω-3 fatty acids in Premature Birth in 92 participants. Completed in 15 May 2020.

Timeline

15 February 2018

Primary endpoint
15 February 2020

15 May 2020

Quick facts

Lead sponsor	Iaso Maternity Hospital, Athens, Greece
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	92
Start date	15 February 2018
Primary completion	15 February 2020
Estimated completion	15 May 2020
Sites	1 location across Greece

Drugs / interventions tested

MCT/ω-3 fatty acids
soybean oil-based IVFE

Conditions studied

Premature Birth — all drugs for Premature Birth →

Sponsor

Iaso Maternity Hospital, Athens, Greece

Who can join

Adults 0 Days to 2 Days, any sex, with Premature Birth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Intravenous administration of pure soybean oil emulsions high in linoleic acid may lead to inflammation and lipid peroxidation in preterm neonates. The aim of the present study was to investigate the effects of a medium-chain triglyceride (MCT)/n-3 polyunsaturated fatty acid (PUFA)-enriched intravenous fat emulsion (IVFE) on plasma fatty acid (FA) profile in preterm neonates. Methods: In this double-blind randomized study, 92 preterm neonates (gestational age \<32 weeks, birth weight \<1500g) were assigned to receive either MCT/n-3 PUFA-enriched IVFE (Intervention Group) or soybean oil-based IVFE (Control Group). Neonates' parents gave their informed written consent for inclusion in the study. Levels of FAs were measured at baseline (day 0) and day 15 of parenteral nutrition with gas-chromatography mass-spectrometry.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Premature Birth

Currently open trials in the same condition.

NCT07490912 — Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <32 Weeks' Gestation and/o · recruiting
NCT07183462 — Azithromycin and Ampicillin for Late PPROM · Phase 4 · recruiting
NCT07306793 — The Effect of PIOMI and Chronobiological Nutrition on Readiness for Feeding, Full Transition to Oral Feeding and Body We · NA · recruiting
NCT06554522 — Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa · Phase 4 · recruiting
NCT06340971 — Air Pollution and Pregnancy · recruiting

Other Iaso Maternity Hospital, Athens, Greece trials

Trials by the same sponsor.

NCT05670613 — Does a Clinical Support System for Parenteral Nutrition (PN) Facilitate the Judgement on Choosing the Most Effective Com · NA · completed
NCT05175378 — Adherence to Mediterranean Diet and Cardiovascular Health in Multiple Sclerosis Female Patients: a Case Control Study · NA · completed
NCT04876560 — Implementation of a CDSS in Oncology Patients During COVID-19 · NA · completed
NCT06380010 — Mediterranean Diet Intervention in Adolescents With Polycystic Ovary Syndrome · NA · completed
NCT03618394 — Bone Turnover and Parenteral Nutrition · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04586608 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Iaso Maternity Hospital, Athens, Greece
Last refreshed: 19 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04586608.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing